Cephalexin For Suspension
Product Images NDC 68180-441

5 FDA label images from Lupin Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cephalexin (NDC 68180-441). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

F21f8728 C3ce 42b7 B08d 8b2cf7edc9d6 01

F21f8728 C3ce 42b7 B08d 8b2cf7edc9d6 01
Chemical structure of cephalexin monohydrate, showing its molecular arrangement including a beta-lactam ring, thiazolidine ring, and side chains, as part of its active pharmaceutical ingredient representation.*
FDA Label Image

F21f8728 C3ce 42b7 B08d 8b2cf7edc9d6 02

F21f8728 C3ce 42b7 B08d 8b2cf7edc9d6 02
Cephalexin for Oral Suspension USP 125 mg/5 mL label from Lupin Pharmaceuticals, Inc. The label states that each 5 mL teaspoonful contains 125 mg cephalexin when reconstituted, with a total volume of 100 mL after mixing. Instructions for mixing, storage conditions before and after mixing, typical pediatric dosing, and manufacturer details are also shown.*
FDA Label Image

F21f8728 C3ce 42b7 B08d 8b2cf7edc9d6 03

F21f8728 C3ce 42b7 B08d 8b2cf7edc9d6 03
Label for Cephalexin for Oral Suspension USP 250 mg/5 mL from Lupin Pharmaceuticals, Inc. This 100 mL bottle (when mixed) contains cephalexin as a dry strawberry flavored mixture requiring reconstitution. The label includes dosing, storage instructions, and manufacturer details, along with barcode and lot/expiration date fields.*
FDA Label Image

F21f8728 C3ce 42b7 B08d 8b2cf7edc9d6 04

F21f8728 C3ce 42b7 B08d 8b2cf7edc9d6 04
Cephalexin for Oral Suspension USP 125 mg/5 mL bottle label from Lupin Pharmaceuticals, Inc. The label indicates this oral suspension contains cephalexin equivalent to 125 mg per 5 mL after reconstitution, with a total volume of 100 mL when mixed. It includes instructions for storage, mixing directions, and pediatric dosing recommendations. The label also displays the NDC 68180-440-01 and manufacturing information for Lupin Pharmaceuticals, Inc.*
FDA Label Image

F21f8728 C3ce 42b7 B08d 8b2cf7edc9d6 05

F21f8728 C3ce 42b7 B08d 8b2cf7edc9d6 05
Cephalexin for Oral Suspension USP 250 mg/5 mL label for a 100 mL bottle. Features include dosage instructions, storage conditions, and reconstitution directions. The label denotes the product is manufactured by Lupin Pharmaceuticals, Inc., with details of the anhydrous cephalexin content per 5 mL teaspoonful. Emphasizes the product is for oral use only, prescription use (Rx only), and requires shaking before use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.